Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

KBTBD8 Activators

KBTBD8 activators encompass a broad spectrum of chemical agents, primarily known for their ability to modulate various cellular signaling pathways. A significant portion of these chemicals target kinases or phosphatases, key enzymes responsible for the addition or removal of phosphate groups on proteins, respectively. For instance, chemicals like LY294002 and Wortmannin inhibit the PI3K pathway, a critical pathway affecting cell growth and survival. Similarly, U0126 and PD98059 target the MAPK/ERK pathway, an essential signaling route involved in cell proliferation.

Given that phosphorylation is a common post-translational modification regulating protein function, chemicals that influence this dynamic, such as Calyculin A and Okadaic acid, have the potential to induce a cascade of cellular events that might touch upon KBTBD8's functionality. Additionally, agents like Forskolin, which elevate cAMP levels, can indirectly influence numerous pathways, given cAMP's role as a secondary messenger in cells.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Activates adenylate cyclase, leading to increased cAMP levels. KBTBD8, being part of cellular signaling, might be influenced by changes in cAMP concentration.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, affecting AKT signaling. Given the interconnection of cellular pathways, PI3K modulation can have downstream effects that touch upon KBTBD8's function.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor which affects cellular growth and proliferation pathways. KBTBD8's function could be influenced within these pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, modulating cellular stress and inflammatory responses. This may indirectly affect KBTBD8's function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, influencing the stress-activated MAPK pathway. This might indirectly touch upon the processes KBTBD8 is involved in.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor, playing a role in cell motility and actin cytoskeleton. KBTBD8 might be affected within this broader pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Another MEK inhibitor, altering the MAPK/ERK pathway. Given the interconnectedness of signaling pathways, KBTBD8 might be indirectly influenced.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor, with the potential to influence pathways where KBTBD8 operates.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Protein phosphatase inhibitor. By affecting phosphorylation states of proteins, KBTBD8's function might be indirectly modulated.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Another protein phosphatase inhibitor, altering the phosphorylation state of various proteins. This can indirectly impact KBTBD8's role.